![Smadar Shakked Samira](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Smadar Shakked Samira
Eerdere bekende functies van Smadar Shakked Samira
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Financieel Directeur/CFO | 01-01-1997 | 01-05-2011 |
Opleiding van Smadar Shakked Samira
Tel-Aviv University | Masters Business Admin |
The Hebrew University of Jerusalem | Undergraduate Degree |
Statistieken
Internationaal
Israël | 3 |
Verenigde Staten | 2 |
Operationeel
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Director of Finance/CFO | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |